Log in

LOGIN / MY PROFILE / LOGOUT

Please remember registration is not considered complete until payment has been received by the BBANYS Central Office. Upon receipt of payment, you will receive a confirmation email. If you have any questions, please contact bbanys@bbanys.org.

Back

April 9, 2025 Webinar - Autoimmune Hemolytic Anemia: New Insights from Preclinical Models

When
Wednesday, April 09, 2025
3:00 PM - 4:00 PM
Location
Online
Spaces left
75

Registration

Institution - Entire series – $200.00
Includes access to all four sessions for current webinar series - do not need to register individually for other sessions in the series
Institution - Only this session – $75.00
Members
Non-Member - Entire series – $130.00
Includes access to all four sessions for current webinar series - do not need to register individually for other sessions in the series
Non-Member - Only this session – $45.00

Register

Wednesday, April 9, 2025 / 3:00 PM - 4:00 PM EDT

Topic:
Autoimmune Hemolytic Anemia: New Insights from Preclinical Models

Speaker:
Krystalyn E. Hudson, PhD
Columbia University

Speaker Bio:

Dr. Krystalyn E. Hudson is an Associate Professor at Columbia University and Co-Director of the Laboratory of Transfusion Biology. She received her PhD from Emory University and completed her postdoctoral fellowship at Scripps Research Institute. Dr. Hudson’s NIH funded research focuses on immune responses to red blood cells (RBCs), which is relevant for transfusion medicine, pregnancy, and transplantation. Her team developed two new innovative preclinical murine models of autoimmune hemolytic anemia (AIHA); these models led to the discovery of a 3-week tolerization window for RBC autoreactive T cells, identified a new T cell subset that predicts tolerance failure and AIHA onset, and revealed new therapeutic targets.

Abstract:

Autoimmune hemolytic anemia is the most frequently reported immune-related adverse event to checkpoint inhibitor immunotherapy. To elucidate the mechanistic underpinnings leading to AIHA, we developed a new preclinical model. This session will discuss findings from this model, highlighting discovery of a new biomarker that predicts AIHA onset and a novel therapeutic target.

Objectives:

Describe a new preclinical model of AIHA
Discuss a new cell subset that can be used to predict AIHA
Describe a new AIHA treatment option

Disclosures:

None

Pricing:

Members: FREE (Registration is required.)
Non-Members: $45 per session & $130 entire series
Institutions: $75 per session & $200 entire series

To receive member pricing, be sure to sign in.

Upcoming Webinars:
March 12, 2025 Webinar - Creating A Culture of Patient Blood Management Within An Organization: The Blood Bank as a Catalyst for Change
Watch for additional sessions in our Spring Webinar Series coming soon!

CONTACT US
Phone: 866-397-8883
Fax: 651-317-8048
Email: bbanys@bbanys.org

ADDRESS
BBANYS
2345 Rice Street, Suite 220
St. Paul, MN 55113

Powered by Wild Apricot Membership Software